Literature DB >> 28069993

Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.

Alon Seifan1, Christine A Ganzer2, Francoise Vermeylen3, Stephen Parry3, Jifeng Zhu4, Abigail Lyons4, Richard Isaacson5, Sarang Kim6.   

Abstract

Background: Understanding health beliefs and how they influence willingness will enable the development of targeted curricula that maximize public engagement in Alzheimer's disease (AD) risk reduction behaviors.
Methods: Literature on behavioral theory and community input was used to develop and validate a health beliefs survey about AD risk reduction among 428 community-dwelling adults. Principal component analysis was performed to assess internal consistency. Linear regression was performed to identify key predictors of Willingness to engage in AD risk reduction behaviors.
Results: The measure as well as the individual scales (Benefits, Barriers, Severity, Susceptibility and Social Norm) were found to be internally consistent. Overall, as Benefits and Barriers scores increased, Willingness scores also increased. Those without prior AD experience or family history had lower willingness scores. Finally, we observed an interaction between age and norms, suggesting that social factors related to AD prevention may differentially affect people of different ages. Conclusions: The Alzheimer Prevention Beliefs Measure provides assessment of several health belief factors related to AD prevention. Age, Family History, Logistical Barriers and total Benefits are significant determinants of willingness to engage in AD risk reduction behaviors, such as seeing a doctor or making a lifestyle change.
© The Author 2017. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  beliefs; health promotion; measurement

Mesh:

Year:  2017        PMID: 28069993      PMCID: PMC6283396          DOI: 10.1093/pubmed/fdw145

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  24 in total

Review 1.  The theory of planned behavior: a review of its applications to health-related behaviors.

Authors:  G Godin; G Kok
Journal:  Am J Health Promot       Date:  1996 Nov-Dec

2.  The Fear of Alzheimer's Disease Scale: a new measure designed to assess anticipatory dementia in older adults.

Authors:  Samantha L French; Mark Floyd; Stacy Wilkins; Sheryl Osato
Journal:  Int J Geriatr Psychiatry       Date:  2011-07-01       Impact factor: 3.485

3.  Cultural diversity and views on Alzheimer disease in older African Americans.

Authors:  Barry W Rovner; Robin J Casten; Lynn F Harris
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Apr-Jun       Impact factor: 2.703

4.  Public beliefs and knowledge about risk and protective factors for Alzheimer's disease.

Authors:  J Scott Roberts; Sara J McLaughlin; Cathleen M Connell
Journal:  Alzheimers Dement       Date:  2014-03-14       Impact factor: 21.566

5.  Apolipoprotein E e4 and Cognitive Function: A Modifiable Association Results from Two Independent Cohort Studies.

Authors:  Laura Perna; Ute Mons; Dan Rujescu; Matthias Kliegel; Hermann Brenner
Journal:  Dement Geriatr Cogn Disord       Date:  2015-10-24       Impact factor: 2.959

6.  Expanding efforts to address Alzheimer's disease: the Healthy Brain Initiative.

Authors:  Lynda A Anderson; Robert Egge
Journal:  Alzheimers Dement       Date:  2014-07-24       Impact factor: 21.566

7.  Validation of screening questions for limited health literacy in a large VA outpatient population.

Authors:  Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn
Journal:  J Gen Intern Med       Date:  2008-03-12       Impact factor: 5.128

8.  Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.

Authors:  Eric R Siemers; Karen L Sundell; Christopher Carlson; Michael Case; Gopalan Sethuraman; Hong Liu-Seifert; Sherie A Dowsett; Michael J Pontecorvo; Robert A Dean; Ronald Demattos
Journal:  Alzheimers Dement       Date:  2015-08-01       Impact factor: 21.566

9.  Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study.

Authors:  Jessica C Agnew-Blais; Sylvia Wassertheil-Smoller; Jae H Kang; Patricia E Hogan; Laura H Coker; Linda G Snetselaar; Jordan W Smoller
Journal:  J Acad Nutr Diet       Date:  2014-09-08       Impact factor: 4.910

10.  Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.

Authors:  Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

View more
  4 in total

1.  Anticipated reactions to learning Alzheimer's disease biomarker results.

Authors:  Lindsay R Clark; Claire M Erickson; Erin M Jonaitis; Yue Ma; Nathaniel A Chin; Kristin Basche; Frederick B Ketchum; Carey E Gleason
Journal:  Alzheimers Res Ther       Date:  2022-06-22       Impact factor: 8.823

2.  Alzheimer's Disease Prevention Health Coaching.

Authors:  A Rhodes; J Inker; J Richardson; F Zanjani
Journal:  J Prev Alzheimers Dis       Date:  2022

3.  Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among the Dutch general population: a cross-sectional study.

Authors:  J Vrijsen; T F Matulessij; T Joxhorst; S E de Rooij; N Smidt
Journal:  BMC Public Health       Date:  2021-05-03       Impact factor: 3.295

4.  Effectiveness of online education for recruitment to an Alzheimer's disease prevention clinical trial.

Authors:  Nabeel Saif; Cara Berkowitz; Susmit Tripathi; Olivia Scheyer; Emily Caesar; Hollie Hristov; Katherine Hackett; Aneela Rahman; Newman Knowlton; George Sadek; Paige Lee; Mark McInnis; Richard S Isaacson
Journal:  Alzheimers Dement (N Y)       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.